Skip to content
Top Menu
  • Subscribe Newsletter
  • 中文
GeneOnline News

GeneOnline News

The Next Generation Biotech Media

MENUMENU
  • Home
  • COVID-19
  • Topics
        • Asia Insight
        • Latest News
        • North America
        • International
  • Technology
  • Feature
  • Industry News
  • BIO Asia-Taiwan
  • Interview
  • Event
  • linkedin

Investment

Industry News / Investment

Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies

2021-01-21 - by GeneOnline - Leave a Comment

On January 19th, Verve Therapeutics announced it raised $94 million in investments as part of a Series B financing. The money will be used to advance the company’s gene-editing therapies, …

Read More
Industry News / M&A

Thermo Fisher Expands Portfolio by Acquiring COVID-19 Diagnostic Company

2021-01-202021-01-20 - by GeneOnline - Leave a Comment

Thermo Fisher Scientific seems to be in the mood for acquiring COVID-19 related testing tools and is spending hundreds of millions on acquiring small to large-sized companies. The latest in …

Read More
Asia Insight / Investment

China’s Gracell Biotechnologies, a CAR-T Therapy Company, Targets 150 Million for IPO

2021-01-12 - by Tyler Chen - Leave a Comment

On January 4th, China-based biotech Gracell Biotechnologies (Gracell) revealed details of the IPO. Gracell is offering 8.8 million American depositary shares (ADS) with 16 to 18 apiece, which will result …

Read More
Investment / North America

Philadelphia Based Biopharma Raises $88 Million in Series A Financing

2021-01-072021-01-07 - by GeneOnline - Leave a Comment

Aro Biotherapeutics, which specializes in the development of tissue-targeted genetic medicines, announced on January 5th that it has managed to secure $88 million in Series A financing from several venture …

Read More
Investment / North America

Investors Bet $120 Million on Ikena Oncology’s Cancer Therapies

2021-01-06 - by GeneOnline - Leave a Comment

The new year has brought good news for Boston-based Ikena oncology, which raised $120 million to push its pipeline of patient-specific, next-generation targeted oncology and immunometabolism therapies. This funding comes …

Read More
Industry News / Investment

Spotlight: The Rise of the SPAC in Biotech

2021-01-052021-01-06 - by GeneOnline - Leave a Comment

What’s a SPAC? Special Purpose Acquisition Companies have become more popular in recent years despite being around for decades. The company has no commercial operations and is formed strictly to …

Read More
Feature / Investment / M&A

GeneOnline’s Top Mergers and Acquisitions of 2020

2020-12-302020-12-30 - by GeneOnline - Leave a Comment

Unlike 2019, when two heavy-hitting pharma acquisition deals illuminated the J.P. Morgan Healthcare Conference, the 2020 event stood in stark contrast featuring none. With the uncertainty surrounding the drug pricing …

Read More
Industry News / M&A

Servier Aims to Expand Portfolio for Hematological Cancers by Acquiring Agios

2020-12-22 - by GeneOnline - Leave a Comment

On December 21st, Servier announced that it would acquire Agios Pharmaceuticals for up to $2 billion. This acquisition will give Servier two FDA approved therapeutics, TIBSOVO, and IDHIFA, as well …

Read More
Deals / International / M&A

Novartis Looks to Diversify Neuroscience Pipeline with $770 Million Worth Acquisition

2020-12-22 - by GeneOnline - Leave a Comment

Cambridge, MA-based Cadent Therapeutics is a privately-held clinical-stage biopharmaceutical company that develops therapies for the treatment of cognitive, mood, and movement disorders with a focus on small molecules targeting neuronal …

Read More
Industry News / Investment

Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies

2020-12-18 - by GeneOnline - Leave a Comment

On December 14th, Locanabio announced it had raised $100 million in a Series B financing. The funding will be used to advance the pre-clinical and clinical development of their CRISPR-mediated …

Read More

Posts navigation

1 2 … 9 Next

TODAY IN HISTORY

June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
Today In History
June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
2018-06-29
Tweets by GeneOnlineNews
  • Home
  • Feature
  • Technology
  • Industry News
  • Event
  • Topics
    • COVID-19
    • Asia Insight
    • International
    • Latest News
    • North America

MEDIA INQUIRIES

service@geneolineasia.com

website

Chinese
Copyright © 2021 GeneOnline News.
Powered by WordPress and HitMag.

[pie_register_login]